Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Entecavir Accord 0.5 mg film-coated tablets – EU/1/17/1211/001
- Exforge FCT 5 mg /80 mg – EU/1/06/370/003
- Nicorette 15mg Inhaler (20 Pack) – PA0330/037/010
- Oxynorm 5mg hard capsules – PA1688/006/004
- Oxynorm Dispersa 10mg Orodispersible tablets – PA1688/006/008
- Pregabalin Krka 75mg hard capsules – PA1347/050/003
- Quentiax SR 50mg Prolonged Release Tablets – PA1347/045/004
- Targocid 200mg Powder and Solvent for Solution for Injection/infusion or oral solution – PA0540/021/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Amoxicillin 250 mg/5 ml powder for oral suspension – PA0126/282/004
- Clonfolic 0.4mg Film Coated Tablets – PA0126/095/00
- Keflex 250 mg Hard Capsules – PA1226/002/001
- Keflex 500mg Film-Coated Tablets – PA1226/002/004
- Palexia 20 mg/ml oral solution – PA2242/012/011
- Xarelto 10 mg film-coated tablets – EU/1/08/472/007
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.